Loading...

Hofseth BioCare ASA

HOFBFPNK
Healthcare
Biotechnology
$0.17
$0.00(0.00%)

Hofseth BioCare ASA (HOFBF) Stock Competitors & Peer Comparison

See (HOFBF) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
HOFBF$0.17+0.00%130.4M-11.00-$0.03N/A
NONOF$68.80-1.63%310.1B18.83$3.71+2.39%
CSLLY$87.93-0.26%170.3B32.33$2.72+1.51%
CMXHF$173.00-1.54%83.8B31.74$5.45+1.60%
UCBJF$211.99-0.73%40.3B32.87$6.45+0.75%
UCBJY$103.49-1.32%39.7B32.19$3.23+0.76%
ARGNF$547.60+0.00%33.5B33.43$16.37N/A
ODTC$22,005.00+29.44%24.1B1.07$20,580.00N/A
IVBXF$12.07+4.96%20.8B-1215.00-$0.01N/A
SBHMY$18.65+6.57%16.7B64.31$0.29+0.96%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

HOFBF vs NONOF Comparison July 2025

HOFBF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HOFBF stands at 130.4M. In comparison, NONOF has a market cap of 310.1B. Regarding current trading prices, HOFBF is priced at $0.17, while NONOF trades at $68.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HOFBF currently has a P/E ratio of -11.00, whereas NONOF's P/E ratio is 18.83. In terms of profitability, HOFBF's ROE is -1.54%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, HOFBF is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for HOFBF.Check NONOF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;